Condition: Nasopharyngeal Carcinoma by AJCC V8 Stage · Sponsor: Chongqing University Cancer Hospital
This is a prospective, single-center clinical trial in eccentric nasopharyngeal carcinoma (NPC) patients. The aim of this study is to evaluate the efficacy and safety of NBI combined with MRI-guided optimized CTV compared with conventional CTV, and to compare the radiotherapy-related adverse events and quality of life between the two groups.
This description comes directly from the study's public registry record.
Yuwei Wang, M.M. · 13436161758 · 38664816@qq.com
Ying Wang, Ph.D,M.D. · 13996412826 · yingwang197011@163.com
Always discuss trial participation with your own doctor first.
| Chongqing University Cancer Hospital | Chongqing, Chongqing Municipality, China | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06167109